These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7737324)

  • 1. Murine macrophage cell lines contain mu 3-opiate receptors.
    Makman MH; Dvorkin B; Stefano GB
    Eur J Pharmacol; 1995 Feb; 273(3):R5-6. PubMed ID: 7737324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.
    Makman MH; Dobrenis K; Surratt CK
    Adv Exp Med Biol; 1998; 437():137-48. PubMed ID: 9666265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine receptors in immunocytes and neurons.
    Makman MH
    Adv Neuroimmunol; 1994; 4(2):69-82. PubMed ID: 7952830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides.
    Cruciani RA; Dvorkin B; Klinger HP; Makman MH
    Brain Res; 1994 Dec; 667(2):229-37. PubMed ID: 7697360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis.
    Makman MH; Bilfinger TV; Stefano GB
    J Immunol; 1995 Feb; 154(3):1323-30. PubMed ID: 7822801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine 6beta glucuronide: fortuitous morphine metabolite or preferred peripheral regulatory opiate?
    Mantione KJ; Goumon Y; Esch T; Stefano GB
    Med Sci Monit; 2005 May; 11(5):MS43-46. PubMed ID: 15874899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
    Beyer A; Koch T; Schröder H; Schulz S; Höllt V
    J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells.
    Dobrenis K; Makman MH; Stefano GB
    Brain Res; 1995 Jul; 686(2):239-48. PubMed ID: 7583289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene.
    Cadet P; Mantione KJ; Stefano GB
    J Immunol; 2003 May; 170(10):5118-23. PubMed ID: 12734358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold stress alters Mytilus edulis pedal ganglia expression of mu opiate receptor transcripts determined by real-time RT-PCR and morphine levels.
    Cadet P; Zhu W; Mantione KJ; Baggerman G; Stefano GB
    Brain Res Mol Brain Res; 2002 Feb; 99(1):26-33. PubMed ID: 11869805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate alkaloids in Ascaris suum.
    Pryor SC; Putnam J; Hoo N
    Acta Biol Hung; 2004; 55(1-4):353-61. PubMed ID: 15270252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.
    Bidlack JM; Frey DK; Kaplan RA; Seyed-Mozaffari A; Archer S
    Mol Pharmacol; 1990 Jan; 37(1):50-9. PubMed ID: 1688995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attempt to structurally convert mu-selective morphine toward delta-receptor binding: dimerization based on enkephalin conformation.
    Yara H; Katagawa Y; Doi M; Ishida T; Inoue M; Yasuda M; Baba A; Iwata H; Kitamura K; Sadatome T
    Eur J Pharmacol; 1990 Jun; 188(6):359-68. PubMed ID: 2164938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.
    Hucks D; Thompson PI; McLoughlin L; Joel SP; Patel N; Grossman A; Rees LH; Slevin ML
    Br J Cancer; 1992 Jan; 65(1):122-6. PubMed ID: 1310249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous morphinergic signaling and tumor growth.
    Cadet P; Rasmussen M; Zhu W; Tonnesen E; Mantione KJ; Stefano GB
    Front Biosci; 2004 Sep; 9():3176-86. PubMed ID: 15353348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of μ-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice.
    Xie N; Gomes FP; Deora V; Gregory K; Vithanage T; Nassar ZD; Cabot PJ; Sturgess D; Shaw PN; Parat MO
    Brain Behav Immun; 2017 Mar; 61():244-258. PubMed ID: 27939249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.